Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inositol hexakisphosphate kinase 2 (IP6K2) is an intracellular enzyme that phosphorylates inositol hexakisphosphate (InsP6) to produce inositol pyrophosphates, notably diphosphoinositol pentakisphosphate (InsP7)[6]. IP6K2 plays critical roles in diverse biological processes, including energy homeostasis, apoptosis, mitochondrial function, neuroprotection, and regulation of cellular signaling. It is distinct for its regulatory effects on mitochondria, influencing cellular responses to metabolic and oxidative stress, and modulates both catalytic (kinase-dependent) and non-catalytic (structural or signaling) functions such as mitophagy and Hedgehog pathway activity[1][2][3][5][6]. Dysregulation of IP6K2 has been implicated in cancer, neurodegenerative diseases, and mitochondrial disorders, marking it as a relevant therapeutic and biological target[2][3][5].
Enzymatic inhibition (e.g. by TNP)[5]; Neuroprotection via restoration of mitochondrial/energy homeostasis (e.g. by NAC)[1][2]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol hexakisphosphate kinase 2 (IP6K2).